+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Cell Cryopreservation Equipment Market Size, Share and Growth Outlook, 2026: Analysis By Product (Freezers, Refrigerators, Liquid Nitrogen Containers, Thawing Systems, Controllers and Data Loggers), By Storage Capacity (Small Capacity, Medium Capacity, Large Capacity), By Application (Biobanking, Stem Cell Research, Drug Discovery, Clinical Diagnostics), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Biobanks & Cell Repositories, Hospitals & Diagnostic Centers) Companies, and Country Forecast, 2021 to 2034

Global Cell Cryopreservation Equipment Market size is forecast to increase from $2.42 Billion in 2026 to $6.25 Billion in 2034 at a CAGR of 12.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006277
Pages: 221 Pages

Cell Counting Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Instruments , Consumables & Accessories ), By Technology Modality (Flow Cytometry, Image-Based Cytometry, Spectrophotometry, Impedance , Microfluidics and Lab-on-Chip Platforms), By Application Area (Clinical and Medical Diagnostics , Life Sciences Research , Industrial and Bioprocess Control ), By End-User (Hospitals and Clinical Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes, Contract Research Organizations and Manufacturing Organizations) Companies, and Country Forecast, 2021 to 2034

Global Cell Counting Market size is forecast to increase from $12.64 Billion in 2026 to $25.37 Billion in 2034 at a CAGR of 9.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006276
Pages: 226 Pages

Cell Banking Outsourcing Market Size, Share and Growth Outlook, 2026: Analysis By Bank Type (Master Cell Banking , Working Cell Banking , Viral Cell Banking , Research & Development Cell Banks), By Cell Type (Stem Cell Banking, Non-Stem Cell ), By Service Phase Offering (Bank Preparation and Cell Line Development, Bank Characterization and Safety Testing, Cryopreservation, Storage, and Long-Term Maintenance, Logistics and Cold-Chain Management), By End-User (Biopharmaceutical and Pharmaceutical Companies, Contract Manufacturing Organizations , Contract Research Organizations , Academic and Government Research Institutes, Hospitals and Transplant Centers) Companies, and Country Forecast, 2021 to 2034

Global Cell Banking Outsourcing Market size is forecast to increase from $14.98 Billion in 2026 to $50.48 Billion in 2034 at a CAGR of 16.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006275
Pages: 226 Pages

Cell and Tissue Preservation Market Size, Share and Growth Outlook, 2026: Analysis By Type (Cell , Tissue ), By Product (Equipment , Kits & Reagents, Media (Bio-preservation Media), Software), By Preservation Technique (Cryopreservation, Ambient Temperature Storage, Temperature-controlled Storage, Drying , Radiation), By Application (Therapeutics, IVF Treatment, Research), By End-User (Biobanks, Hospitals & Clinics, Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Cell and Tissue Preservation Market size is forecast to increase from $5.99 Billion in 2026 to $13.9 Billion in 2034 at a CAGR of 11.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006274
Pages: 229 Pages

Cell and Tissue Analysis Products Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Instruments , Consumables , Software & Analysis Tools), By Technology (Flow Cytometry, Next-Generation Sequencing , Polymerase Chain Reaction , Microscopy & High-Content Screening , Cell Separation & Isolation Technologies), By Cell Type (Human Cells, Animal Cells, Microbial Cells), By Application (Drug Discovery & Development, Clinical Diagnostics, Basic Research & Life Sciences, Regenerative Medicine), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, Healthcare & Clinical Settings) Companies, and Country Forecast, 2021 to 2034

Global Cell and Tissue Analysis Products Market size is forecast to increase from $16.45 Billion in 2026 to $38.74 Billion in 2034 at a CAGR of 11.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006273
Pages: 213 Pages

Cell and Gene Therapy Third-Party Logistics Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Transportation Services , Warehousing & Storage Services , Packaging and Labeling Services, Regulatory Compliance & Customs Brokerage), By Temperature Range (Cryogenic Storage , Ultra-Low Temperature Storage , Refrigerated Storage , Ambient Storage ), By Product Type (Cell Therapies , Gene Therapies ), By End-User (Biopharmaceutical Companies, Contract Manufacturing Organizations , Clinical Research Organizations , Hospitals & Medical Centers) Companies, and Country Forecast, 2021 to 2034

Global Cell and Gene Therapy Third-Party Logistics Market size is forecast to increase from $15.86 Billion in 2026 to $38.88 Billion in 2034 at a CAGR of 11.86% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006272
Pages: 221 Pages

Cell and Gene Therapy Supply Chain Software Market Size, Share and Growth Outlook, 2026: Analysis By Software Type (Chain of Custody , Manufacturing Execution Systems , Enterprise Resource Planning , Supply Chain Management , Quality Management Systems , Laboratory Information Management Systems ), By Deployment Model (Cloud-Based , On-Premise), By Application (Cell Therapy Supply Chain Management , Gene Therapy Supply Chain Management, Patient Scheduling and Enrollment, Inventory and Cryogenic Storage Management), By End-User (Biopharmaceutical & Biotechnology Companies, Contract Development and Manufacturing Organizations , Hospitals & Treatment Centers, Research and Academic Institutes) Companies, and Country Forecast, 2021 to 2034

Global Cell and Gene Therapy Supply Chain Software Market size is forecast to increase from $462.91 Million in 2026 to $1476.25 Million in 2034 at a CAGR of 15.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006271
Pages: 214 Pages

Cell and Gene Therapy Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Cell Therapy , Gene Therapy ), By Vector Type (Viral Vectors , Non-Viral Vectors ), By Application (Oncology, Rare & Genetic Disorders, Musculoskeletal, Cardiology & Neurology, Ophthalmology, Immunology), By Delivery Mode (Ex vivo Administration, In vivo Administration), By End-User (Hospitals & Clinics, Specialty Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Cell and Gene Therapy Market size is forecast to increase from $12.42 Billion in 2026 to $48.62 Billion in 2034 at a CAGR of 18.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006270
Pages: 213 Pages

Cell and Gene Therapy Manufacturing Services Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Cell Therapy Manufacturing, Gene Therapy Manufacturing), By Scale (Pre-commercial , Commercial Scale), By Mode of Operation (In-house Manufacturing, Contract ), By Workflow (Cell Processing, Cell Banking, Process Development, Vector Production, Fill & Finish Operations, Analytical and Quality Testing, Raw Material Testing), By Indication (Oncology, Rare Diseases, Cardiovascular Diseases, Orthopedic Diseases, Infectious Diseases) Companies, and Country Forecast, 2021 to 2034

Global Cell and Gene Therapy Manufacturing Services Market size is forecast to increase from $17.9 Billion in 2026 to $83.9 Billion in 2034 at a CAGR of 21.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006269
Pages: 226 Pages

Cell and Gene Therapy Clinical Trials Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Cell Therapy, Gene Therapy), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, Genetic Disorders, Musculoskeletal, Rare Diseases, Autoimmune Diseases, Other Indications), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs)) Companies, and Country Forecast, 2021 to 2034

Global Cell and Gene Therapy Clinical Trials Market size is forecast to increase from $16.58 Billion in 2026 to $55.11 Billion in 2034 at a CAGR of 16.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006268
Pages: 210 Pages